Skip to main content
. 2002 Mar;53(3):243–249. doi: 10.1046/j.0306-5251.2001.01560.x

Table 2.

Average of spirometric values during the last three weeks of each treatment.

Placebo Diltiazem Nifedipine
FVC (l)% predicted 3.86±0.07 79±1% 3.98±0.08 81±1% 3.95±0.09 81±2%
FEV1 (l)% predicted 3.06±0.05 80±2% 3.08±0.0679±2 3.09±0.0780±2
FEF25–75 (l s−1)% predicted 2.73±0.13 66±4% 2.67±0.13 64±4% 2.76±0.15 66±4%